- Enterprise.
- Attested
- Not disclosed
- —
- —
- US
Bayesian Health
by Bayesian Health · US
First-ever FDA-cleared continuous AI sepsis monitor (May 2026).
First-ever FDA-cleared continuous AI sepsis monitor (May 2026).
Free tier available. HIPAA-attested.
EHR-integrated sepsis early warning + clinical surveillance. First FDA 510(k) for continuous AI sepsis monitoring (May 2026).
What it costs
Free tier only; no paid plans publicly disclosed.
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Plan | — | — | Enterprise. |
Source: vendor pricing page. Verified May 23, 2026.
What deploys cleanly
Carries FDA 510(k), HIPAA per vendor documentation. Independent attestation review is the buyer's responsibility before clinical deployment.
What the literature says
1 peer-reviewed study indexed on PubMed evaluate Bayesian Health in clinical contexts. The most relevant are shown below, ranked by editorial relevance score combining title match, study design, recency, and journal tier.
- Lessons in machine learning model deployment learned from sepsis.
- Lyons PG, Singh K· Med· 2022
- In three recent and related publications, researchers from Johns Hopkins University and Bayesian Health report results from implementing and prospectively evaluating the Targeted Real-time Early Warning System (TREWS) for sepsis at five hospitals..
Other decision support
See the full decision support ranking
UpToDate Expert AI
by Wolters Kluwer
Gold-standard curated CDS with generative AI layer.
~$559/year individual + Enterprise.|HIPAA
OpenEvidence
by OpenEvidence
Free physician-only literature-grounded Q&A, 1M consults/day.
Free for NPI-verified physicians (ad-funded).
Doximity GPT
by Doximity
Physician AI suite (post Pathway acquisition Aug 2025).
Free for Doximity members (ad-funded).DynaMed / Dyna AI
by EBSCO Health
Evidence-curated reference with AI Q&A and strong hospital integration.
Institutional + ~$395/year individual.
